Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Urology
|
November 11, 2024
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
Patrick Campbell, Georges Gebrael, Arshit Narang, et al.
Urologic Oncology
|
August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
Nishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
Prostate Cancer and Prostatic Diseases
|
January 30, 2025
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy
Georges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, et al.
Clinical Genitourinary Cancer
|
May 2, 2026
Differential Tumor Response Patterns and Extent of Necrosis After Immunotherapy Combinations Predict Clinical Responses for Renal Cell Carcinoma
Wadih Issa, Nicolas Sayegh, Damla Gunenc, et al.
JAMA Network Open
|
July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
Chadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
European Urology Oncology
|
May 12, 2024
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy
Vinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, et al.
JCO Precision Oncology
|
May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI
Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
Clinical Genitourinary Cancer
|
December 12, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
Neal S Chawla, Nicolas Sayegh, Nishita Tripathi, et al.
JAMA Network Open
|
May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US
Vinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Urology
|
November 11, 2024
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
Patrick Campbell, Georges Gebrael, Arshit Narang, et al.
Urologic Oncology
|
August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
Nishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
Prostate Cancer and Prostatic Diseases
|
January 30, 2025
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy
Georges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, et al.
Clinical Genitourinary Cancer
|
May 2, 2026
Differential Tumor Response Patterns and Extent of Necrosis After Immunotherapy Combinations Predict Clinical Responses for Renal Cell Carcinoma
Wadih Issa, Nicolas Sayegh, Damla Gunenc, et al.
JAMA Network Open
|
July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
Chadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
European Urology Oncology
|
May 12, 2024
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy
Vinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, et al.
JCO Precision Oncology
|
May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI
Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
Clinical Genitourinary Cancer
|
December 12, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
Neal S Chawla, Nicolas Sayegh, Nishita Tripathi, et al.
JAMA Network Open
|
May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US
Vinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Page
of 8